Impax Laboratories, Inc., et al. v. Lannett Holding Inc., et al., C.A. No. 14-984 - RGA, December 1, 2015.

Andrews, J.  Claim construction opinion issues regarding three terms from two patents.  A Markman hearing took place on November 16, 2015

The disputed technology relates to pharmaceutical formulations. The following terms were considered:

  1. “preambles”
  2. “zolmitriptan”
  3. “buffer”, “buffered”, “in a buffer”